HCA Healthcare, Inc. (HCA) Financial Statements

HCA Healthcare, Inc.

HCA · NYSE

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Total Revenue	$75.60B	$70.60B	$64.97B	$60.23B	$58.75B	$51.53B	$51.34B	$46.68B
Selling, General & Administrative	$548.00M	$421.00M	$353.00M	$307.00M	$337.00M	$416.00M	$370.00M	$344.00M
Operating Expenses	$65.77B	$62.08B	$57.26B	$51.65B	$48.92B	$46.10B	$46.09B	$41.34B
Interest Expense	$2.25B	$2.06B	$1.94B	$1.74B	$1.57B	$1.58B	$1.82B	$1.75B
Income Before Taxes	$9.83B	$8.52B	$7.71B	$8.58B	$9.83B	$5.43B	$5.24B	$5.33B
Provision for Income Taxes	$2.05B	$1.87B	$1.61B	$1.75B	$2.11B	$1.04B	$1.10B	$946.00M
Net Income	$6.78B	$5.76B	$5.24B	$5.64B	$6.96B	$3.75B	$3.50B	$3.79B
Basic EPS	$28.70	$22.27	$19.25	$19.43	$21.52	$11.10	$10.27	$10.90
Diluted EPS	$28.33	$22.00	$18.97	$19.15	$21.16	$10.93	$10.07	$10.66
Basic Shares Outstanding	236.41M	258.60M	272.40M	290.35M	323.31M	338.27M	341.21M	347.30M
Diluted Shares Outstanding	239.50M	261.81M	276.41M	294.67M	328.75M	343.61M	348.23M	355.30M

Analyst Estimates

Period	Consensus EPS	Low	High	Estimates	Revisions
Dec 2026	$29.45	$29.09	$30.02	6	↑2 ↓4
Dec 2027	$32.33	$30.30	$33.99	10	↑2 ↓5
Dec 2028	$36.46	$33.77	$38.82	6	↑2 ↓0
Dec 2029	$38.03	$38.03	$38.03	1	↑0 ↓0

Forward estimates are the sell-side consensus reported by Nasdaq, not a metir forecast.

Symbol: HCA
Type: Stock
Sector: Health Care
Industry: Hospital/Nursing Management
Country: North America
Exchange: NYSE

Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 47 million annual patient encounters to advance science, improve patient care and save lives.

Key Issues

Bullish view

Revenue rose from $70.6 billion to $75.6 billion and net income increased from $5.8 billion to $6.8 billion in fiscal 2025, supporting the case that operating growth can justify a premium valuation.

Bearish view

Morgan Stanley said it was reassessing HCA's growth prospects under current market conditions while cutting its target from $425 to $380, indicating that recent growth may not translate into sufficient forward upside.

Analyst Consensus

See all

Buy

23 analysts

$410

Current

$475

Low

$463

Average

$485

High

Average target implies +12.75% versus the current price.

Earnings History

BeatMissNo estimate

Peers

3M Company